Company / PP&E per Share
10x Genomics, Inc. PP&E per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$1.85
FY2025
5-year range
$1.56 / $2.57
FY2021-FY2025
Trend
-12.6%
vs FY2024
Sector context
#80 of 133
Health Care
What the data says
At $1.85, 10x Genomics, Inc.'s pp&e per share ranks #80 of 133 in the Health Care sector. PP&E per Share has declined for 3 consecutive years, from $2.57 in FY2022 to $1.85 in FY2025.
Based on SEC 10-K filings.
1.85 in FY2025 with a 5-year CAGR of +19.6%.
Declined from $2.43 to $1.85 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -10.3%
- 5-Year CAGR
- +19.6%
- 10-Year CAGR
- -
Sector benchmark
#80 of 133 in Health CareTop 60% of 133This company $1.85 Sector average $11.65
▼
-84.1% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 12.6% year-over-year.
- Ranks #80 out of 133 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.85 | -12.6% |
| FY2024 | $2.12 | -12.6% |
| FY2023 | $2.43 | -5.6% |
| FY2022 | $2.57 | +64.6% |
| FY2021 | $1.56 | +106.4% |
| FY2020 | $0.76 | -77.4% |
| FY2019 | $3.36 | +303.9% |
| FY2018 | $0.83 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026